Cessation of TKIs Patients With CML in Stable Deep Molecular Remission: 3-Year Follow-Up and Prognostic Factors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission
J. Clin. Oncol 2024 Mar 12;[EPub Ahead of Print], FX Mahon, M Pfirrmann, S Dulucq, A Hochhaus, P Panayiotidis, A Almeida, J Mayer, H Hjorth-Hansen, JJWM Janssen, S Mustjoki, J Martinez-Lopez, H Vestergaard, H Ehrencrona, K Machová Poláková, U Olsson-Strömberg, G Ossenkoppele, MG Berger, G Etienne, J Dengler, TH Brümmendorf, A Burchert, D Réa, P Rousselot, FE Nicolini, WK Hofmann, J Richter, S SausseleFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.